articleTop 1% cited
Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm
Gynecologic Oncology · 2009 · Vol. 114(1) · pp. 26–31
S. Dennis✉(Memorial Sloan Kettering Cancer Center)Eric Eisenhauer(Memorial Sloan Kettering Cancer Center)Oliver Zivanovic(Memorial Sloan Kettering Cancer Center)Yukio Sonoda(Memorial Sloan Kettering Cancer Center)Nadeem R. Abu‐Rustum(Memorial Sloan Kettering Cancer Center)Douglas A. Levine(Memorial Sloan Kettering Cancer Center)Matthew W. Guile(Johns Hopkins Bayview Medical Center)Robert E. Bristow(Johns Hopkins University)Carol Aghajanian(Memorial Sloan Kettering Cancer Center)Richard R. Barakat(Memorial Sloan Kettering Cancer Center)
Ovarian cancer diagnosis and treatmentIntraperitoneal and Appendiceal MalignanciesEndometrial and Cervical Cancer TreatmentsMedicineDebulkingAscitesOvarian cancerHazard ratioSurgeryStage (stratigraphy)ChemotherapyEpithelial ovarian cancerProgression-free survival
MeSH terms
AdultAgedAged, 80 and overCombined Modality TherapyFemaleHumansMiddle AgedNeoplasm StagingOvarian NeoplasmsTime FactorsSurvival RatePlatinum CompoundsSurvivorsDisease-Free SurvivalTaxoids
Citations
590
FWCI
30.07
field-weighted impact
References
37
Percentile
100%
vs. same field & year
Citations per year
References
Neoadjuvant Chemotherapy or Primary Debulking Surgery in Advanced Ovarian Carcinoma: A Retrospective Analysis of 285 Patients
Gynecologic Oncology · 1998 · 391 citations
Relative influences of tumor volume before surgery and the cytoreductive outcome on survival for patients with advanced ovarian cancer: a prospective study
Gynecologic Oncology · 2003 · 413 citations
Platinum-based neoadjuvant chemotherapy and interval surgical cytoreduction for advanced ovarian cancer: A meta-analysis
Gynecologic Oncology · 2006 · 398 citations
Cancer Statistics, 2008
CA A Cancer Journal for Clinicians · 2008 · 10,197 citations
The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with stages IIIC–IV epithelial ovarian cancer
Gynecologic Oncology · 2006 · 350 citations
What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)?
Gynecologic Oncology · 2006 · 628 citations
Improved optimal cytoreduction rates for stages IIIC and IV epithelial ovarian, fallopian tube, and primary peritoneal cancer: a change in surgical approach
Gynecologic Oncology · 2004 · 321 citations
Survival Effect of Maximal Cytoreductive Surgery for Advanced Ovarian Carcinoma During the Platinum Era: A Meta-Analysis
Journal of Clinical Oncology · 2002 · 2,313 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.